NCT06754254View on ClinicalTrials.gov

Blood Biomarkers from Internal Jugular Vein for the Diagnosis of Alzheimer's Disease

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

March 21, 2019

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Alzheimer Disease
Interventions
DIAGNOSTIC_TEST

blood biomarkers from the internal jugular vein

blood biomarkers (Aβ42/40, p-tau217, p-tau181, NFL, GFAP, etc.) from the internal jugular vein

Trial Locations (1)

400042

Daping Hospital, Chongqing

All Listed Sponsors
lead

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

OTHER

NCT06754254 - Blood Biomarkers from Internal Jugular Vein for the Diagnosis of Alzheimer's Disease | Biotech Hunter | Biotech Hunter